Dye strongly persistent

Slides:



Advertisements
Similar presentations
The EMERALD Trial Diabetic Substudy. EMERALD Diabetic Analysis To compare myocardial perfusion and infarct sizes in diabetic and non-diabetic patients.
Advertisements

Protection Devices in PCI-Treatment of Myocardial Infarction for Salvage of Endangered Myocardium Study Presented at American College of Cardiology Scientific.
Unstable Angina: Embolism Can Occur Prior to PCI Thrombus in proximal RCA Stain of muscle before injection begins: TIMI Myocardial perfusion grade 1 CM.
on behalf of the TOTAL Investigators
Intracoronary Serotonin and Endothelin Release After PCI / Stenting Taylor AJ. Am Heart J Aug;148(2): e10 Leosco et al, AJC 1999;84:
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
The AiMI Trial Arshad Ali, MD, David Cox, MD, Nabil Dib, MD, Bruce Brodie, MD, Daniel Berman, MD, Navin Gupta, MD, Kevin Browne, MD, Robert Iwaoka, MD,
Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.
Clinical Trial Results. org C. Michael Gibson, M.S., M.D. Director TIMI Data Coordinating Center Invasive Cardiologist Beth Israel Deaconess Medical Center.
Is PCI necessary for AMI related artery with TIMI 3 flow ? Donghoon Choi Yonsei Cardiovascular Center Yonsei University College of Medicine.
Primary Angioplasty and Hemodynamic Support in Cardiogenic Shock Department of Internal Medicine, College of Medicine, Yonsei University Hyuck Moon Kwon,
Angiographic Estimates of Myocardium at Risk During Acute Myocardial Infarction: a Validation Study Using Cardiac MRI José T. Ortiz, Sheridan N. Meyers,
Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.
The Impact of Thrombus Aspiration on 1-year Mortality in Primary PCI for ST-Elevation Myocardial Infarction, ACSIS 2010 Experience Mady Moriel, Shlomi.
Beyond TIMI 3 Flow CTFC < 14 CTFC > % (n=41) (n = 18/640) (n =35/563) 2.8% p= “TIMI 4” Flow TIMI 3 Flow 14 < CTFC < % % Risk of In Hospital.
TIMI 14 Antman et al. Circ 99: 2720,1999 Phases of Trial ControlInvestigational Accel tPA Accel tPA Accel tPA rPA ( U) rPA ( U) No lytic Abx.
The 90 Minute Wall: 60% Rates of TIMI Grade 3 Flow % TIMI 3 Flow.
UNIVERSITÄT LEIPZIG H E R Z Z E N T R U M Infarct transmurality and infarct size assessed by delayed enhancement magnetic resonance imaging: Association.
Relationship of Ultrasound Plaque Characteristics to TMPG Following Intracoronary Stenting ↓ TMPG Post PCINo Δ or ↑ TMPGp-value Pre-PCI Plaque Area12.4.
Proof of Concept #1: Occluded Arteries Cause Acute MI Proof of Concept #1: Occluded Arteries Cause Acute MI Proof of Concept #2: Drugs (in this case IC.
A Prospective, Randomized Evaluation of Supersaturated Oxygen Therapy After Percutaneous Coronary Intervention in Acute Anterior Myocardial Infarction.
LESSON 1 LESSON 1 Establishment of:
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Trial Vignettes 1-3 Mark Mason Harefield Hospital Royal Brompton and Harefield NHS Trust.
PROTECT: What Have We Learned Lesson 2: TMPG is associated with clinical and biomarker outcomes following PCI.
Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Anti-Platelet and Anti-Thrombotic.
The MASTER Trial A Prospective, Randomized, Multicenter Evaluation of a PET Micronet Mesh Covered Stent (MGuard) in STEMI Sigmund Silber, MD, PhD FESC,
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Randomized Early versus Late AbciXimab in Acute Myocardial Infarction treated with primary coronary intervention (RELAx-AMI Trial) Mauro Maioli M.D., Francesco.
High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
SPEED : GUSTO-IV PILOT GUSTO-IV Pilot Trial. SPEED : GUSTO-IV PILOT Rationale for Combination Therapy in AMI Enhance Incidence and Speed of Reperfusion.
Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic.
Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented at.
Randomized Early versus Late Abciximab in Acute Myocardial Infarction Treated With Primary Coronary Intervention (RELAx-AMI Trial) Mauro Maioli, MD, Francesco.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for percutaneous coronary intervention.
Date of download: 7/11/2016 Copyright © The American College of Cardiology. All rights reserved. From: Small molecule glycoprotein IIb/IIIa receptor inhibitors.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.
Total Occlusion Study of Canada (TOSCA-2) Trial
IABP-SHOCK II Score Stratifies Patient Risk in CS after AMI
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
Intra Coronary AdjunctivE Tenecteplase During Primary PCI for STEMI:
Circ Cardiovasc Interv
No Reflow Reflow P value Arrhythmia 40% 18% Lecture Notes
Presented by Dr. Leif Thuesen
European Society of Cardiology 2003
PROTECT – TIMI 30 Trial Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Anti-Platelet.
Published in the European Heart Journal
Randomized Comparison in the Setting of Acute MI
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
Impact of Platelet Reactivity Following Clopidogrel Administration
American College of Cardiology Presented by Dr. Michel R. Le May
In STEMI Complete Reperfusion (TFG 3, TMPG 3, ST Res  70%) is Associated with a Greater Percent of Receptors Occupied by Integrilin 52.0% % Pts With Complete.
Myocardial Staining (TMPG 1)  Post-Stent in AMI
52.0% Complete Resolution TFG 3 TMPG 3 ST Resolution  70% p=0.006
TIMI Myocardial Perfusion (TMP) Grades Dye strongly persistent
Role of Stenting in Acute MI: PAMI Stent Pilot Trial
Dye strongly persistent
Maintenance of Long-Term Clinical Benefit with
A New Angiographic Risk Score in Facilitated PCI
Association of Troponin Elevation with Risk of Mortality in Acute Coronary Syndromes Mortality at 42 Days  % A study by Antman and.
MRI Hyperenhancement is Associated with Myonecrosis Following PCI
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial
INTRO AMI. INTEGRILIN AND. REDUCED DOSE. OF THROMBOLYTIC IN. ACUTE
Evolution of Myocardial Blush after MI
GUSTO 1 Trial 41,000 patients enrolled, landmark study
ESPRIT INTEGRITI TACTICS Rate of Increase in DSA
Dye strongly persistent
Presentation transcript:

Dye strongly persistent Other Angiographic Efficacy Endpoint: TIMI Myocardial Perfusion (TMP) Grades TMP Grade 3 TMP Grade 2 TMP Grade 1 TMP Grade 0 Normal ground glass appearance of blush Dye mildly persistent at end of washout Dye strongly persistent at end of washout Gone by next injection Stain present Blush persists on next injection No or minimal blush 6.2% 5.1% Mortality (%) p = 0.05 4.4% Lecture Notes: While the TIMI flow grades and the TIMI frame count assess flow in the epicardial arteries, the TIMI Myocardial Perfusion Grades (TMPG) assesses flow at the tissue level. Views are chosen to minimize superimposition of non-infarcted territories in the assessment of the culprit artery’s TMP Grade. The duration of cinefilming should be equal to or exceed 3 cardiac cycles in the washout phase to assess the washout of the myocardial blush. Care should be taken not to mistake filling of the venous system such as the great cardiac vein as blush. Blush is assessed during the same phase of the cardiac cycle as it may be less intense during diastole. TIMI Myocardial Perfusion Grade 0: Failure of dye to enter the microvasculature. Either minimal or no ground glass appearance (“blush”) or opacification of the myocardium in the distribution of the culprit artery indicating lack of tissue level perfusion. TIMI Myocardial Perfusion Grade 1: Dye slowly enters but fails to exit the microvasculature. There is the ground glass appearance (“blush”) or opacification of the myocardium in the distribution of the culprit lesion that fails to clear from the microvasculature, and dye staining is present on the next injection (approximately 30 seconds between injections). TIMI Myocardial Perfusion Grade 2: Delayed entry and exit of dye from the microvasculature. There is the ground glass appearance (“blush”) or opacification of the myocardium in the distribution of the culprit lesion that is strongly persistent at the end of the washout phase (i.e. dye is strongly persistent after 3 cardiac cycles of the washout phase and either does not or only minimally diminishes in intensity during washout). TIMI Myocardial Perfusion Grade 3: Normal entry and exit of dye from the microvasculature. There is the ground glass appearance (“blush”) or opacification of the myocardium in the distribution of the culprit lesion that clears normally, and is either gone or only mildly/moderately persistent at the end of the washout phase (i.e. dye is gone or is mildly/moderately persistent after 3 cardiac cycles of the washout phase and noticeably diminishes in intensity during the washout phase), similar to that in an uninvolved artery. Blush that is of only mild intensity throughout the washout phase but fades minimally is also classified as grade 3. References: Gibson CM, et al. Circulation. 2000;101:125-130 2.0% n = 203 n = 46 n = 79 n = 434 Gibson et al, Circulation 2000 Neumann F-J, Blasini R, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation. 1998;98:2695-2701.

Not All TIMI Grade 3 Flow is Created Equally: Among Patients. With Successful Lysis, There is a 7 Fold Range in Mortality P = 0.007 5.4% 2.9% % Mortality 0.7% Lecture Notes This slide illustrates that not all TIMI Grade 3 flow is created equally. Every patient shown here had successful reperfusion with TIMI Grade 3 Flow. However, if the myocardium was occluded (TMPG Grades 0/1 on the right), the mortality remained elevated at 5.4%. It is not until both the epicardial artery and the myocardium are open (TMPG 3 shown on the far left), that the mortality was lowest in acute MI, below 1%. References: Gibson CM, et al. Circulation. 2000;101:125-130 N = 278 N = 136 N = 34 Myocardial Perfusion Grade 3 Myocardial Perfusion Grade 2 Myocardial Perfusion Grades 0/1 Gibson CM, et al. Circulation. 2000;101:125-130.

TIMI 10 B: Independent Predictors of 2 Year Mortality Pre-PCI Epicardial and Myocardial Flow Are Independently Associated with 2 Year Mortality TIMI Grade 3 Flow RR 0.61, p=0.047 TIMI Myocardial Blush RR 0.50, p = 0.038 In a MV model correcting for : Performance of PCI Age Gender Pulse Anterior MI Lecture Notes While 90 minute TIMI Flow Grades (TFG), Corrected TIMI Frame Counts (CTFC) and TIMI Myocardial Perfusion Grades (TMPG) have been associated with 30 day outcomes, we hypothesized that these indices would be related to long term outcomes following thrombolytic administration. As a substudy of the TIMI 10B trial (tPA vs TNK), 49 centers carried out 2 year follow-up. TIMI Grade 2/3 Flow (Cox Hazard Ratio, HR = 0.41, p=0.001), reduced CTFCs (faster flow, p=0.02) and an open microvasculature (TMPG 2/3) (HR = 0.51, p=0.038) were all associated with improved 2 year survival. Rescue percutaneous coronary intervention (PCI) of closed arteries (TFG 0/1) at 90 minutes was associated with reduced mortality (p=0.03) and mortality trended lower with adjunctive PCI of open (TFG 2/3) arteries (p=0.11). In a multivariate model correcting for previously identified correlates of mortality (age, gender, pulse, LAD infarction, and any PCI during initial hospitalization), patency (TFG 2/3) (HR=0.32, p<0.001), CTFC (p=0.01) and TMPG 2/3 remained associated with reduced mortality (HR=0.46, p=0.02). Both improved epicardial flow (TFG 2/3 and low CTFCs) and tissue level perfusion (TMPG 2/3) at 90 minutes after thrombolytic administration are independently associated with improved 2 year survival, suggesting complementary mechanisms of improved long-term survival. While rescue PCI reduced long-term mortality, improved microvascular perfusion (TMPG 2/3) before PCI was also related to improved mortality independent of epicardial blood flow and the performance of rescue or adjunctive PCI. Further prospective trials are warranted to re-examine the benefit of early PCI with thrombolysis. 1. Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E for the TIMI Study Group. Relationship of the TIMI Myocardial Perfusion Grades, TIMI Flow Grades and TIMI Frame Count to Long Term Outcomes Following Thrombolytic Administration. Circulation, 2002, in press. Gibson et al, Circulation 2002

Myocardial Perfusion After Primary PCI is Strongest Predictor of Mortality Myocardial Blush Grades 100 90 360 900 1440 2250 2790 3 n=148 2 95 n=393 3 0/1 90 n=236 Cumulative Survival (%) Final Blush Score (patients with final TIMI grade 3 flow) 2 85 Time (days) van ‘t Hof AWJet al. Circulation 1998; 97:2302-6. Blush 1-Year Mortality 0/1 3 6.8% 80 Relation of Myocardial Perfusion Grade to Mortality 2 13.2% P=0.004 MBG 0/1 (n=100) MBG 2 (n=74) MBG 3 (n=79) P Death at 30 days 26.0% 9.9% 3.9% <0.001 Death at 1 year 35.1% 13.4% 9.4% Death during F/U 39.0% 18.3% 12.4% 0/1 18.3% 75 2 4 6 8 10 12 Stone GW, et al. J Am Coll Cardiol. 2002;39:591-597. Independent Angiographic Variables as Risk Factors of Long-Term Mortality in Patients With TIMI Grade 3 flow After Angioplasty RR* 95% CI P MBG 0 and 1 vs 2 and 3 2.9 1.4 to 5.8 0.003 MVD 2 and 3 vs 1 2.3 1.1 to 4.7 0.02 LAD vs non-LAD MI 2.2 1.1 to 4.4 0.03 TIMI flow before: 0 to 2 vs 3 1.8 0.5 to 6.1 0.31 Haagar PK, et al. J Am Coll Cardiol. 2003;41:532-538 2 of 3 pts have a closed muscle after 10 PCI Mortality goes up 3 fold Henriques JP, et al. Circulation. 2003;107:2115-2119.

Myocardial Blush and Mortality: CADILLAC Results Costantini, J Am Coll Cardiol 2004;44:305–12

Independent Contribution of Myocardial Blush and ST Resolution to Survival The myocardial blush and ST resolution following primary PCI are independently related to long term survival in acute myocardial infarction Hagger et al, J Am Coll Cardiol, 2003

Further Risk Stratification Provided by the TMPG among Patients with TIMI 3 Flow or TIMI 2/3 flow Martinez-Rios MA, Am J Cardiol 2004;93:280–287.

Combining TIMI Flow and Perfusion Grades Martinez-Rios MA, Am J Cardiol 2004;93:280–287.